A share price of NRX Pharmaceuticals Inc [NRXP] is currently trading at $0.56, up 10.87%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The NRXP shares have gain 23.05% over the last week, with a monthly amount glided 27.27%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
On 21, March 2024, NRx Pharmaceuticals to Report Fourth Quarter and Full Year 2023 Financial Results and Provide a Corporate Update on March 28, 2024. In a post published today on Yahoo Finance, NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) (“NRx Pharmaceuticals”, the “Company”), a clinical-stage biopharmaceutical company, today announced that it will release its fourth quarter and full year 2023 financial results after the market closes on Thursday, March 28, 2024, via press release, which will be available on the Company’s website at https://ir.nrxpharma.com/press-releases. The Company will host a conference call to discuss the financial results as well as provide a corporate update at 4:30 p.m. ET the same day.
From an analyst’s perspective:
NRX Pharmaceuticals Inc experienced fluctuations in its stock price throughout the past year between $0.22 and $1.20. Currently, Wall Street analysts expect the stock to reach $2 within the next 12 months. NRX Pharmaceuticals Inc [NASDAQ: NRXP] shares were valued at $0.56 at the most recent close of the market. An investor can expect a potential return of 257.14% based on the average NRXP price forecast.
Analyzing the NRXP fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -2.53, Equity is 69.77 and Total Capital is 5.36. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of-1.62.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.5133 points at the first support level, and at 0.4667 for the second support level. However, for the 1st resistance point, the stock is sitting at 0.6033, and for the 2nd resistance point, it is at 0.6467.
NRX Pharmaceuticals Inc [NRXP] reported earnings per share of -$0.07 for its fiscal quarter that ended on 9/29/2023. Based on the Wall Street analysts’ estimates, the company was expected to report earnings of -$0.11/share, meaning a difference of $0.04 and a surprise factor of 36.40%. By comparison, the stated earnings for the previous quarter ended on 6/29/2023 were -$0.12 per share as compared to estimates of -$0.14 per share, a difference of $0.02 representing a surprise of 14.30%.
Ratios To Look Out For
To put it in perspective, the Current Ratio for NRX Pharmaceuticals Inc [NASDAQ:NRXP] is 0.68. As well, the Quick Ratio is 0.68, while the Cash Ratio is 0.46.
Transactions by insiders
Recent insider trading involved Hurvitz Chaim, Director, that happened on Aug 30 ’23 when 70000.0 shares were purchased. Director, Gorovitz Aaron completed a deal on Aug 30 ’23 to buy 35000.0 shares. Meanwhile, Chief Scientist Javitt Jonathan C bought 100000.0 shares on Aug 23 ’23.
